Olema Pharmaceuticals, Inc. (OLMA)
6.99
-0.34
(-4.64%)
USD |
NASDAQ |
Oct 30, 16:00
6.99
0.00 (0.00%)
After-Hours: 17:24
Olema Pharmaceuticals Cash from Operations (Quarterly) : -45.90M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.90M |
| March 31, 2026 | -45.99M |
| December 31, 2025 | -38.33M |
| September 30, 2025 | -34.53M |
| June 30, 2025 | -29.88M |
| March 31, 2025 | -43.98M |
| December 31, 2024 | -26.28M |
| September 30, 2024 | -27.02M |
| June 30, 2024 | -27.56M |
| March 31, 2024 | -23.50M |
| December 31, 2023 | -18.48M |
| September 30, 2023 | -22.74M |
| June 30, 2023 | -22.12M |
| Date | Value |
|---|---|
| March 31, 2023 | -20.39M |
| December 31, 2022 | -19.71M |
| September 30, 2022 | -17.99M |
| June 30, 2022 | -26.46M |
| March 31, 2022 | -17.90M |
| December 31, 2021 | -18.60M |
| September 30, 2021 | -12.10M |
| June 30, 2021 | -8.905M |
| March 31, 2021 | -11.08M |
| December 31, 2020 | -9.013M |
| September 30, 2020 | -7.536M |
| June 30, 2020 | -1.181M |
| March 31, 2020 | -2.136M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 1.624M |
| SELLAS Life Sciences Group, Inc. | -7.588M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 40.84M |
| Cash from Financing (Quarterly) | 1.107M |
| Free Cash Flow | -164.96M |
| Free Cash Flow Per Share (Quarterly) | -0.4415 |
| Free Cash Flow to Equity (Quarterly) | -45.82M |
| Free Cash Flow to Firm (Quarterly) | -46.12M |
| Free Cash Flow Yield | -24.56% |